JaCVAM affiliated organizations | Japanese Center for the Validation of Alternative Methods, National Institute of Health Science

List of JaCVAM affiliated organizations

Categories

JaCVAM Committee
Validation Management Team
Other
ICATM

JaCVAM Committee

Committees in Active
All Committees

[01] Advisory Committee

Advisory Committee

	Name	Affiliation
Chairperson	Yukihiro Goda	National Institute of Health Sciences
	Chie Hamaguchi	Manufacturing Industries Bureau, Ministry of Economy
	Yoko Hirabayashi	Center for Biological Safety and Research, National Institute of Health Sciences
	Masamitsu Honma	Japanese Environmental Mutagen and Genome Society
	Tomohiro Ishioka	Food Safety and Consumer Affairs Bureau, Forestry and Fisheries, Ministry of Agriculture
	Norito Kato	Japanese Society for Cutaneous Immunology and Allergy
	Toru Kawanishi	Food Safety Commission of Japan
	Masato Kitagaki	Japan Cosmetic Industry Association
	Satoshi Numazawa	Japanese Society of Toxicology
	Tokuo Sukata	Japan Chemical Industry Association
	Mutsumi Suzuki	Japan Pharmaceutical Manufacturers Association
	Hiroaki Todo	Japanese Society for Alternatives to Animal Experiments
	Hideshi Tsusaki	Japan Association of Contract Laboratories for Safety Evaluation
	Takaji Wakita	National Institute of Infectious Diseases
	Kazuto Watanabe	Japanese Association for Laboratory Animal Science
	Keiko Yamazaki	Japanese Coalition for Animal Welfare
	Kunihiko Yamazaki	Environmental Health Department, Ministry of the Environment
	Tokunori Yokota	Japan Crop Protection Association
	Yasunori Yoshida	Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour and Welfare

* Affiliation is at the time of inauguration

Report
Advisory Committee
- 2009 to 2010 the 3rd proceeding November 19th ,2010 2010_3rdmeeting.pdf
- 2009 to 2010 the 2nd proceeding November 11th ,2009 2009_2ndmeeting.pdf
- 2009 to 2010 the 1st proceeding March 5th ,2009 2009_1stmeeting.pdf
- 2007 to 2008 the 4th proceeding July 8th ,2008 2008_4thmeeting.pdf
- 2007 to 2008 the 3rd proceeding February 21st ,2008 2008_3rdmeeting.pdf
Restricted site

[02] Regulatory Acceptance Board

Restricted site

[03] Steering Committee

Steering Committee

	Name	Affiliation
Chairperson	Yoko Hirabayashi	Center for Biological Safety and Research, National Institute of Health Sciences
	Takao Ashikaga	Division of Risk Assessment, National Institute of Health Sciences
	Osamu Fueki	Pharmaceuticals and Medical Devices Agency
	Yukihiro Goda	National Institute of Health Sciences
	Akiko Hayashi	Evaluation and Licensing Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour and Welfare
	Koji Ishii	National Institute of Infectious Diseases
	Yasunari Kanda	Division of Pharmacology, National Institute of Health Sciences
	Satoshi Kitajima	Division of Toxicology, National Institute of Health Sciences
	Kenichi Masumura	Division of Risk Assessment, National Institute of Health Sciences
	Kumiko Ogawa	Division of Pathology, National Institute of Health Sciences
	Takayuki Okubo	Office of Chemical Safety, Evaluation and Licensing Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour and Welfare
	Keiichi Sugiyama	Division of Genetics and Mutagenesis, National Institute of Health Sciences
	Yuhji Taquahashi	Animal Care Section, Division of Toxicology, National Institute of Health Sciences
	Masaaki Tsukano	Office of Chemical Safety, Evaluation and Licensing Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour and Welfare
	Masahiko Yokota	Pharmaceuticals and Medical Devices Agency

* Affiliation is at the time of inauguration

Restricted site

[04] Editorial Committee: Skin Irritancy Test

Restricted site

[05] Editorial Committee: Phototoxicity Test

Restricted site

[06] Editorial Committee: Skin Sensitization Test

Restricted site

[07] Editorial Committee: Eye Irritation Test

Restricted site

[08] Editorial Committee: Pyrogen Screening Test

Editorial Committee: Metabolic Activity Test

	Name	Affiliation
Chairperson	Yutaka Kikuchi	Chiba Prefectural University of Health Sciences
	Takao Ashikaga	Division of Risk Assessment, National Institute of Health Sciences
	Osamu Fueki	Pharmaceuticals and Medical Devices Agency
	Katsuhiko Hayashi	Division of Microbiology, National Institute of Health Sciences
	Shoji Iwakiri	Chugai Pharmaceutical Co., Ltd.
	Yukiko Kudo	Division of Microbiology, National Institute of Health Sciences
	Takuo Mizukami	National Institute of Infectious Diseases
	Masashi Muroi	Musashino University
	Yukari Nakagawa	Pharmaceutical and Medical Device Regulatory Science Society of Japan
	Kazuyuki Nakashima	KM Biologics Co., Ltd.
	Kenji Ohya	Division of Microbiology, National Institute of Health Sciences
	Daisuke Yamada	Takeda Pharmaceutical Co., Ltd.

* Affiliation is at the time of inauguration

Restricted site

[09] Editorial Committee: Acute Toxicity Test

Restricted site

[10] Editorial Committee: Corrosion Test

Restricted site

[11] Editorial Committee: Skin Absorption Test

Restricted site

[12] Editorial Committee: Genotoxicity Test

Restricted site

[13] Editorial Committee: Cell Transformation Test

Restricted site

[14] Editorial Committee: Endocrine Disrupter Screening

Restricted site

[15] Editorial Committee: Metabolic Activity Test

Editorial Committee: Metabolic Activity Test

	Name	Affiliation
Chairperson	Takuo Ogihara	Faculty of Pharmacy, Takasaki University of Health and Welfare
	Hiroshi Arakawa	Faculty of Pharmacy, Takasaki University of Health and Welfare
	Seiichi Ishida	Division of Pharmacology, National Institute of Health Sciences
	Eri Kajiwara	Pharmaceuticals and Medical Devices Agency
	Akiko Koeda	Ina Research Inc.
	Shinichi Miura	Daiichi Sankyo Company, Limited.
	Naomi Nagai	Pharmaceuticals and Medical Devices Agency
	Takuya Nagao	Sumika Chemical Analysis Service, Ltd.
	Miki Nakajima	Faculty of Pharmaceutical Sciences, Kanazawa University

* Affiliation is at the time of inauguration (Term of appointment has expired)

Restricted site

[16] Editorial Committee: Reproductive Toxicity Test

Restricted site

[17] Editorial Committee: Glossary

Restricted site

[18] Editorial Committee: GIVMP

Restricted site

[19] Editorial Committee: Physiologically Biokinetic Test

Restricted site

[20] Editorial Committee: Receptor Binding Assay

Restricted site

[21] Editorial Committee: Developmental Neurotoxicity Test

Restricted site

[22] Editorial Committee: Oral Toxicity Test

Restricted site

[23] Editorial Committee: In Silico Toxicology

Restricted site

[24] Stakeholder Meeting

Stakeholder Meeting

	Registered Organizations
1	International Life Sciences Institute Japan (ILSI Japan)
2	Japan Association of Contract Laboratories for Safety Evaluation (JACL)
3	Japan Chemical Industry Association (JCIA)
4	Japan Chemical Industry Ecology-Toxicology & Information Center (JETOC)
5	Japan Cosmetic Industry Association (JCIA)
6	Japan Crop Protection Association (JCPA)
7	Japan Pharmaceutical Manufacturers Association (JPMA)
8	Japanese Association for Laboratory Animal Science (JALAS)
9	Japanese Coalition for Animal Welfare
10	Japanese Environmental Mutagen and Genome Society (JEMS)
11	Japanese Society for Alternatives to Animal Experiments (JSAAE)
12	Japanese Society for Cutaneous Immunology and Allergy(JSCIA)
13	Japanese Society of Immunotoxicology (JSIT)
14	Japanese Society of Toxicology (JSOT)
15	Japanese Society of Toxicologic Pathology (JSTP)
16	Safety Evaluation Forum (SEF)

* Organizations are listed in alphabetical order

Restricted site

[25] Editorial Committee: AI-SHIPS

Restricted site

Validation Management Team

Teams in Active
All Teams

[01] Comet Assay	Restricted site
[02] Vitrigel-EIT	Restricted site
[03] ROS Assay	Restricted site
[04] SIRC-CVS Assay	Restricted site
[05] IL-8 Luc Assay	Restricted site
[06] LabCyte CORNEA-MODEL	Restricted site
[07] Hand1-Luc EST	Restricted site
[08] MITA	IL-2 Luc LTT Restricted site IL-1 Luc Restricted site IL-2 Restricted site
[09] ADRA	Restricted site
[10] LbL-3D Skin	Restricted site
[11] EpiSensA	Restricted site
[12] MylcMat	Restricted site
[13] Skin Irritation of Medical Device Extracts	Restricted site
[14] α-Sens	Restricted site

Other

[01] Zebrafish collaborative study	Restricted site
[02] BCOP	Restricted site
[03] Other	Restricted site
[04] Other	Restricted site

ICATM

ICATM	Restricted site